Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Comparative Study - Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration
Authors not listed
Instituto de Olhos de Goiania · 2009
Abstract
To report the short term anatomic and visual acuity response after intravitreal injection of bevacizumab and ranibizumab in patients with choroidal neovascularization secondary to age-related macular degeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Anonymous. (2009). Comparative Study - Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration. <em>Instituto de Olhos de Goiania</em>. https://clinicaltrials.gov/study/NCT01014468
Vancouver
Anonymous. Comparative Study - Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration. Instituto de Olhos de Goiania. 2009.
BibTeX
@misc{anon2009Compar,
title = {Comparative Study - Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration},
author = {Anonymous},
journal = {Instituto de Olhos de Goiania},
year = {2009},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Instituto de Olhos de Goiania 2005
Open access · US-GOV
Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration
Ophthalmology 2012
Preprint · OA
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Klinikum Bremen-Mitte, gGmbH 2008
Open access · US-GOV
Prevention of Vision Loss in Patients With Age-Related Neovascular Macular Degeneration by Intravitreal Injection of Bevacizumab and Ranibizumab in a Typical Outpatient Setting
Vastra Gotaland Region 2020
Open access · US-GOV
The Sahlgrenska Anti-VEGF (SAHLVE) Study - a Prospective Randomized Double-blind Comparison of Bevacizumab and Aflibercept in Patients With Neovascular Age-related Macular Degeneration
American Journal of Ophthalmology 2006
Citation only
Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration
Springer eBooks 2007
Citation only